Controlled, cross‐sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demand

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2516|21|2|171-179

ISSN： 1351-8216

Source： HAEMOPHILIA, Vol.21, Iss.2, 2015-03, pp. : 171-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on‐demand therapy with activated factor VII in severe haemophilia A patients with inhibitors, in Spain

By  

HAEMOPHILIA, Vol. 21, Iss. 3, 2015-05 ,pp. : 320-329

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vitamin D status in Well‐Controlled Caucasian HIV Patients in Relation to Inflammatory and Metabolic Markers – A Cross‐Sectional Cohort Study in Sweden

By  

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (ELECTRONIC), Vol. 82, Iss. 1, 2015-07 ,pp. : 55-62

John Wiley & Sons Inc

Access to resources Recommend Favorite

A cross‐sectional study of bleeding phenotype in haemophilia A carriers

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 2, 2015-07 ,pp. : 223-228

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight®) in previously treated patients with severe haemophilia A: interim results of the guardian™2 extension trial

By  

HAEMOPHILIA, Vol. 21, Iss. 5, 2015-09 ,pp. : e436-e439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight®) in previously treated patients with severe haemophilia A: interim results of the guardian™2 extension trial

By  

HAEMOPHILIA, Vol. 1351-8216, Iss. 5, 2015-09 ,pp. : e436-e439

John Wiley & Sons Inc

Access to resources Recommend Favorite